Psychedelics Investing Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto
psychedelics investing Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia & Company
psychedelics investing Lobe Sciences Announces Additional Details Regarding the Acquisition of Altemia & Company
psychedelics investing Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia
psychedelics investing Lobe Sciences to Present at Sequire Cannabis & Psychedelics Conference April 5, 2023
psychedelics investing Lobe Sciences Ltd. Announces That The Drug Enforcement Administration Has Issued The Initial 2023 Quota Allowing Export Of L-130
psychedelics investing Chronic Cluster Headaches No More: The Promise Of Lobe Sciences' At-Home Psychedelic Treatments Without The Trip!
psychedelics investing Lobe Sciences Ltd. Announces Exclusive Collaboration with Quality Chemical Laboratories LLC
Forte Minerals Appoints Patrick Evans as Non-Executive Chairman and Announces the Resignation of Long-Standing Director Doug Turnbull
